ArticleFrontiers in pharmacology2022

LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer.

Jiahao Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.